The bio-tech market has shown significant activities around
Intuitive Surgical Inc. (ISRG). Strs Ohio, Horizon Investments, Oppenheimer Asset Management, US Bancorp, Danske Bank, and Wealthfront Advisers have increased their stake in the company, indicating a strong institutional investor's interest. Multiple insider trading instances and RSU grants show confidence within the company's management. Intuitive Surgical's board members have exercised a significant number of Restricted Stock Units (RSUs), hinting at their belief in the company's growth potential. On market performance, despite certain pullbacks and weakness, analysts are largely bullish on the company.
Truist has maintained a buy rating and even though there's a recent reduction in its price target by BITG, its valuation is considered strong with anticipation of sustainable growth. The reports about the company beating Q1 expectations and earnings forecasts are indicative of its strong financial performance. The company's significant achievements made include its successful buyback initiative and completion of the da Vinci and Ion Distribution Business acquisition. Despite some security breaches, the company has managed to maintain its market edge.
Intuitive Surgical ISRG News Analytics from Wed, 22 Oct 2025 07:00:00 GMT to Sat, 02 May 2026 14:35:47 GMT -
Rating 8
- Innovation 7
- Information 7
- Rumor -8
